Literature DB >> 36092510

Antigen presentation by cardiac fibroblasts promotes cardiac dysfunction.

Njabulo Ngwenyama1, Kuljeet Kaur1, Darrian Bugg2, Brandon Theall1, Mark Aronovitz1, Robert Berland1, Smaro Panagiotidou3, Caroline Genco1, Mercio A Perrin3, Jennifer Davis2, Pilar Alcaide1.   

Abstract

Heart failure (HF) is a leading cause of morbidity and mortality. Studies in animal models and patients with HF revealed a prominent role for CD4+ T cell immune responses in the pathogenesis of HF and highlighted an active crosstalk between cardiac fibroblasts and IFNγ producing CD4+ T cells that results in profibrotic myofibroblast transformation. Whether cardiac fibroblasts concomitantly modulate pathogenic cardiac CD4+ T cell immune responses is unknown. Here we show report that murine cardiac fibroblasts express major histocompatibility complex type II (MHCII) in two different experimental models of cardiac inflammation. We demonstrate that cardiac fibroblasts take up and process antigens for presentation to CD4+ T cells via MHCII induced by IFNγ. Conditional deletion of MhcII in cardiac fibroblasts ameliorates cardiac remodelling and dysfunction induced by cardiac pressure overload. Collectively, we demonstrate that cardiac fibroblasts function as antigen presenting cells (APCs) and contribute to cardiac fibrosis and dysfunction through IFNγ induced MHCII.

Entities:  

Year:  2022        PMID: 36092510      PMCID: PMC9451034          DOI: 10.1038/s44161-022-00116-7

Source DB:  PubMed          Journal:  Nat Cardiovasc Res        ISSN: 2731-0590


  38 in total

Review 1.  CD28, CTLA-4 and their ligands: who does what and to whom?

Authors:  D M Sansom
Journal:  Immunology       Date:  2000-10       Impact factor: 7.397

2.  Distinct pathways of antigen uptake and intracellular routing in CD4 and CD8 T cell activation.

Authors:  Sven Burgdorf; Andreas Kautz; Volker Böhnert; Percy A Knolle; Christian Kurts
Journal:  Science       Date:  2007-04-27       Impact factor: 47.728

3.  CD4+ T cells promote the transition from hypertrophy to heart failure during chronic pressure overload.

Authors:  Fanny Laroumanie; Victorine Douin-Echinard; Joffrey Pozzo; Olivier Lairez; Florence Tortosa; Claire Vinel; Christine Delage; Denis Calise; Marianne Dutaur; Angelo Parini; Nathalie Pizzinat
Journal:  Circulation       Date:  2014-03-21       Impact factor: 29.690

Review 4.  Atypical MHC class II-expressing antigen-presenting cells: can anything replace a dendritic cell?

Authors:  Taku Kambayashi; Terri M Laufer
Journal:  Nat Rev Immunol       Date:  2014-10-17       Impact factor: 53.106

Review 5.  Understanding TCR affinity, antigen specificity, and cross-reactivity to improve TCR gene-modified T cells for cancer immunotherapy.

Authors:  Timothy T Spear; Brian D Evavold; Brian M Baker; Michael I Nishimura
Journal:  Cancer Immunol Immunother       Date:  2019-10-08       Impact factor: 6.968

6.  Regulation of Trypanosoma cruzi infection in mice by gamma interferon and interleukin 10: role of NK cells.

Authors:  F Cardillo; J C Voltarelli; S G Reed; J S Silva
Journal:  Infect Immun       Date:  1996-01       Impact factor: 3.441

7.  Targeted Ablation of Periostin-Expressing Activated Fibroblasts Prevents Adverse Cardiac Remodeling in Mice.

Authors:  Harmandeep Kaur; Mikito Takefuji; C Y Ngai; Jorge Carvalho; Julia Bayer; Astrid Wietelmann; Ansgar Poetsch; Soraya Hoelper; Simon J Conway; Helge Möllmann; Mario Looso; Christian Troidl; Stefan Offermanns; Nina Wettschureck
Journal:  Circ Res       Date:  2016-05-02       Impact factor: 17.367

8.  Antigen presentation by human dermal fibroblasts: activation of resting T lymphocytes.

Authors:  D T Umetsu; D Katzen; H H Jabara; R S Geha
Journal:  J Immunol       Date:  1986-01       Impact factor: 5.422

9.  Targeting cardiac fibrosis with engineered T cells.

Authors:  Haig Aghajanian; Toru Kimura; Joel G Rurik; Aidan S Hancock; Michael S Leibowitz; Li Li; John Scholler; James Monslow; Albert Lo; Wei Han; Tao Wang; Kenneth Bedi; Michael P Morley; Ricardo A Linares Saldana; Nikhita A Bolar; Kendra McDaid; Charles-Antoine Assenmacher; Cheryl L Smith; Dagmar Wirth; Carl H June; Kenneth B Margulies; Rajan Jain; Ellen Puré; Steven M Albelda; Jonathan A Epstein
Journal:  Nature       Date:  2019-09-11       Impact factor: 49.962

Review 10.  Redefining the identity of cardiac fibroblasts.

Authors:  Michelle D Tallquist; Jeffery D Molkentin
Journal:  Nat Rev Cardiol       Date:  2017-04-24       Impact factor: 32.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.